Advertisement

Antineoplastics

Hepatitis-B virus reactivation: 14 case reports

    • 39 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Atilla PA, et al. Hepatitis B reactivation rate and fate among multiple myeloma patients receiving regimens containing lenalidomide and/or bortezomib. Turkish Journal of Hematology 36: 266-273, No. 4, Dec 2019. Available from: URL: http://doi.org/10.4274/tjh.galenos.2019.2019.0103

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Antineoplastics. Reactions Weekly 1786, 34 (2020) doi:10.1007/s40278-020-73508-6

    Download citation